Skip to main content

Jeff M Sands

NIH Rank #12847
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1883596Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$1.3M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#12,847
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Jeff M Sands. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Jeff M Sands as a PI. Multi-PI records show the full award amount for context.

  • 2R44DK127798-02R44
    Novel AMPK activator for treatment of congenital X-linked nephrogenic diabetes insipidus in pediatric patients
    $1.1M
    award amount
  • 5U2CDK129501-04U2C
    Atlanta Network for Training In KUH Scientific Research (ATLANTIS)
    $161K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Jeff M Sands as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Nephrodi Therapeutics, Inc.
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  5. 2026
    $2M Cumulative Funding
  6. 2026
    Entered Top 50% Nationally
    Ranked #7922

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Jeff M Sands.